Medico Remedies Limited has secured a substantial government supply order worth ₹37,17,62,439 from Uttar Pradesh Medical Supplies Corporation Limited, as disclosed under Regulation 30 of the SEBI Listing Regulations. The pharmaceutical manufacturer announced this development on January 26, 2026, highlighting a significant business milestone for the company.

Order Details and Scope

The contract involves supplying multiple drugs to Uttar Pradesh Medical Supplies Corporation Limited, an entity formed by the Government of Uttar Pradesh. This corporation serves as the centralized procurement and distribution hub for medicines and health supplies across the state, ensuring timely and effective healthcare services to the people of Uttar Pradesh.

Contract Terms and Timeline

The company has committed to completing the full order supply by October 31, 2026, providing a clear execution timeline for this government contract. The order falls under domestic entity classification, strengthening Medico Remedies' position in the government healthcare supply sector.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with sub-para 4, Part B of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that:

• No promoter, promoter group, or group companies have any interest in the awarding entity
• The transaction does not fall within related party transactions
• All terms and conditions are as per the contract specifications

Company Background

Medico Remedies Limited operates as a WHO-GMP and ISO 9001-2015 certified pharmaceutical formulations manufacturer. The company holds the distinction of being a government-recognized star export house, demonstrating its established credentials in pharmaceutical manufacturing and supply. Based in Mumbai, the company specializes in manufacturing pharmaceutical formulations and maintains multiple digital platforms for business operations.

This government order represents a significant addition to Medico Remedies' business portfolio, reinforcing its capabilities in large-scale pharmaceutical supply operations and government sector engagement.

Medico Remedies has announced securing a substantial order worth ₹73.00 crore, marking a significant business development for the pharmaceutical company. The order represents a notable addition to the company's order book and demonstrates market confidence in its product offerings.

Order Details and Business Impact

The secured order, valued at ₹73.00 crore, constitutes a material business development for Medico Remedies. This substantial order value reflects the company's ability to secure significant contracts in the pharmaceutical sector.

Market Position

With a current market capitalisation of ₹390.00 crore, Medico Remedies operates as a mid-cap pharmaceutical company. The secured order represents approximately 18.72% of the company's total market value, underscoring its material significance to the overall business operations.

Business Significance

The order win demonstrates several key aspects of Medico Remedies' business position:

• Strong market demand for the company's pharmaceutical products
• Ability to secure substantial contracts in competitive markets
• Enhanced order book providing revenue visibility
• Validation of the company's product quality and market positioning

This development strengthens Medico Remedies' business prospects and provides a solid foundation for future operations in the pharmaceutical sector.